FDA Inspection 1029517 — Diazyme Laboratories Inc.

Diazyme Laboratories Inc. — FEI 1000122044

The FDA completed an inspection of Diazyme Laboratories Inc. on Aug 23, 2017 in West Caldwell, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 23, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
West Caldwell, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.